Under construction – not a live service
Sign in
Not yet taking people in IndiaNo phase

Mobile App to Support Medicine Routines in Schizophrenia

Tests whether a phone app helps adults with schizophrenia or schizoaffective disorder take medicine.

Plain-language title generated from the registry record
Registry title: Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA

Key facts

Where
Palakkad, IndiaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Source: NCT06474325, who can take part

Where in India

  • Government Medical College,Palakkad, IndiaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Pittsburgh
Trial code
NCT06474325
Record updated
16 September 2026
Original description
A new mental health application will be developed for persons with schizophrenia and schizoaffective disorder. The aim is to look at whether it is feasible to use a mobile health application for improving medication adherence in persons with schizophrenia and schizoaffective disorder and whether it is acceptable to that population.Read full original descriptionShow less

Feasibility and Acceptability of Mobile Mental Health Application for the Improvement of Medication Adherence in Persons With Schizophrenia(SZ) and Schizoaffective Disorder(SZA)

A new mental health application will be developed for persons with schizophrenia and schizoaffective disorder. The aim is to look at whether it is feasible to use a mobile health application for improving medication adherence in persons with schizophrenia and schizoaffective disorder and whether it is acceptable to that population.

Inclusion: Persons diagnosed with schizophrenia and schizoaffective disorder and are in remission for past two months; Age 18-60 years of any gender; Able to read and understand Malayalam/ English.

Exclusion: History of substance use (except nicotine); Having any serious physical illness. -; Patients who have active psychotic or mood symptoms.

ClinicalTrials.gov NCT06474325